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Abstract
Introduction The neurotransmitter dopamine has frequently
been implicated in reward processing but is also, increasingly,
implicated in punishment processing. We have previously
shown thatbothpatients with Parkinson's disease and healthy
individuals with low dopamine (DA) synthesis are better at
reversal learning based on punishment than reward. Here, we
extend these prior findings by examining the effects of
artificially reducing DA synthesis in healthy individuals
performing this previously employed task.
Methods In a double-blind, placebo-controlled crossover
design, we applied the acute tyrosine and phenylalanine
depletion (ATPD) procedure to reduce global DA synthesis in
15 female and 14 male subjects. Each subject performed the
reward- and punishment-based reversal-learning paradigm.
Results There was a significant three-way interaction bet-
ween ATPD, the valence of the outcome signalling reversal
andthegenderoftheparticipants.Examinationofpunishment
and reward-based reversals separately revealed that this was
driven by a significant improvement in punishment process-
ing in female but not male subjects following DA depletion.
Conclusions Reducing DA synthesis in healthy individuals
shifted sensitivity of performance from reward to punish-
ment processing. Gender differences in DA synthesis might
underlie the selectivity of this effect to female subjects.
Such gender biases may go some way towards explaining
the gender biases in certain psychiatric disorders such as




Adequate adaptation to the environment requires the anticipa-
tion of biologically relevant events, i.e., rewards and punish-
ments,bylearningsignalsoftheiroccurrence.However,inour
constantly and rapidly changing environment, this learning
has to be highly flexible. In financial markets, for instance,
stocksthatwerepreviouslygrowinginvaluecansuddenlyand
rapidlyplummet; previouslyvaluable possessionscanbecome
valueless. The emerging field of neuroeconomics seeks to
understand the neural and pharmacological underpinnings of
the flexible value-baseddecision making necessaryto adapt to
such changes (Sanfey et al. 2006).
It is thought that flexible outcome-dependent learning
occurs when predicted and actual outcomes differ (i.e.,
prediction errors). A putative mechanism for prediction
error learning is the phasic firing of midbrain dopamine
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DOI 10.1007/s00213-010-1880-1(DA) neurones (Schultz 1998). The striatum, which is a
target of these dopamine neurones, has frequently been
implicated in reward-based prediction error learning (Frank
et al. 2004; Frank 2005; Cools et al. 2006b, 2009). Recent
work has extended this to show that individual differences
in DA synthesis capacity within the striatum can predict the
extent to which individuals learn from reward and
punishment prediction errors (Cools et al. 2009). Individ-
uals with high dopamine synthesis capacity were shown to
be better at reversal based on unexpected reward than
unexpected punishment, while individuals with low DA
synthesis capacity were better at reversal based on
unexpected punishment than unexpected reward. The DA
D2 receptor agonist bromocriptine affected reversal in a
baseline-dependent manner. It improved reward-based
relative to punishment-based learning in those with low
DA synthesis whilst impairing it in those with high DA
synthesis, likely reflecting an ‘inverted U’-shaped relation-
ship between DA levels and cognitive performance,
whereby both too much and too little DA result in sub-
optimal behaviour. Contrary to the pervasive hypothesis
that DA plays a greater role in reward than in punishment
processing, effects of bromocriptine on punishment-based
reversal in this study were actually more robust than those
on reward-based reversal. This is consistent with previously
observed disproportionate effects of dopaminergic medica-
tion withdrawal on punishment-based learning in patients
with Parkinson's disease (PD) (Cools et al. 2006a; Frank et
al. 2007b) and with a growing literature implicating the
striatum in punishment-based prediction error learning
(Frank 2005; Seymour et al. 2007; Cohen and Frank 2009).
It is difficult to determine, however, whether the
punishment-selective effects of dopaminergic drugs in these
prior studies reflect a general property of DA's effect on
learning or whether they reflect specifics of the employed
approaches. For example, bromocriptine's specific effect on
punishment-based reversal might reflect its relative selectivity
for (presynaptic) DA D2 receptors (Frank 2005; Frank et al.
2007a; Cools et al. 2009). Moreover, punishment-selective
effects of dopaminergic medication in PD might be restricted
to PD, in which receptors are influenced asymmetrically and
in which there is a spectrum of changes in addition to the DA
alterations. In the present study, we therefore extended our
prior research by reducing DA synthesis in healthy individ-
uals via the acute phenylalanine and tyrosine depletion
(APTD) procedure. This procedure is a dietary manipulation
that reduces DA by depriving the brain of its amino acid
precursors and is thought to both reduce overall DA synthesis
and reduce DA transmission at all postsynaptic DA receptor
subtypes (Montgomery et al. 2003). Here, we employed a
reversal-learning task that disentangles reward and punish-
ment processing and that has previously been shown to be
sensitive to DA manipulation (Cools et al. 2006a, 2009).
Based upon our prior work with this task, we predicted that
non-selectively reducing DA via ATPD would disproportion-
atelyinfluencepunishmentprocessingoverrewardprocessing.
Furthermore, given the above-described baseline-dependency
of the effects of dopaminergic manipulations (Cools et al.
2009), and given that there is an association between gender
and variation in baseline DA (females have significantly
higher striatal dopamine synthesis capacity than males
(Laakso et al. 2002; Haaxma et al. 2007)), we recruited
enough males and females to include gender as an effect of
interest in analysis of task performance.
In this study, we therefore examined the effects of DA
depletion in healthy males and females performing the
same reward- and punishment-based reversal-learning task
previously employed in studies on bromocriptine and
levodopa (Cools et al. 2006a).
Materials and methods
Procedures were approved by the Hertfordshire Research
Ethics Committee (08/H0311/25). All participants gave
written informed consent prior to commencing the study.
Testing took place at the Wellcome Trust Clinical Research
Facility in Addenbrooke's hospital in Cambridge.
Subjects
From the Cambridgeshire area, 15 female and 14 male
subjects aged between 19 and 49 years (mean, 27.28 years;
standard deviation, 7.00) were recruited through email and
poster advertisements. Two female participants withdrew
because they felt unwell following the amino acid drink
(one on visit 1, one on visit 2).
Prior to recruitment all participants were screened by
telephone interview to ensure that they met the study criteria.
The exclusion criteria were as follows: cigarette smoking,
history of psychiatric disorder or neurological disorder,
history of major illness, first degree relative with a history of
axis 1 psychiatric disorder, drug abuse, excessive alcohol
intake, head injury resulting in unconsciousness and current
use of psychoactive medication. Subjects were excluded
following initial interview. They were also independently
interviewedbytraineeclinicianHSandbynursingstaffonthe
research ward on their first visit to the hospital. Subject
demographic and trait characteristics are reported in Table 1.
Acute phenylalanine/tyrosine depletion (APTD) procedure
Participants made two visits to the clinical research facility,
which were separated by at least a week. On the day
188 Psychopharmacology (2010) 211:187–195preceding their visit, they were instructed to follow a low
proteindiet(lessthan20gprotein)andthentofastfrom7pm.
They arrived on the test day at approximately 9.15 am. Upon
arrival, they were asked to complete a set of visual analogues
scales(VAS)todeterminemoodstate.TheVASconsistedofa
number of questions including “how happy are you?” to
which subjects had to respond by making a mark on a 10-cm
line. A baseline sampleof blood was then obtained, following
which, the amino acid drink was given. For males, the TYR
drink contained 15 g isoleucine, 22.5 g leucine, 17.5 g lysine,
5 g methionine, 17.5 g valine, 10 g threonine and 2.5 g
tryptophan. The BAL drink contained the same but with the
addition of 12.5 g tyrosine and 12.5 g phenylalanine. Female
subjects received 20% less of each amino acid in order to
account for a lower average body weight. The amino acids
were dissolved in approximately 300 ml of water, and lemon
flavouring was added to make the drink more palatable.
Fourteen subjects (seven females) received the TYR drink on
their first visit and the BAL on their second visit. This order
was reversed for the other 14 (seven females) participants.
Drink order was randomly assigned, and both the participant
and the researcher were blind to which drink was being
administered. Participants were unable to distinguish between
the drinks. After consuming the drink, the participants were
given free time, although asked to remain at the research
facility. They had unlimited access to water, and at 12 pm,
they were given an apple to avoid hypoglycaemia and hunger
(this technique was shown to be effective in prior tryptophan
depletion studies (Robinson et al. 2009; Robinson and
Sahakian 2009)). Approximately 4.5 h after consuming the
drink, a second blood sample was taken; the VAS ratings
were taken once again. Neuropsychological testing was then
carried out, and once completed, participants were given a
meal and allowed to go home. Data from additional tasks
completed on the same day will be presented elsewhere and
clearly cite this paper.
Neuropsychological testing
Reward and punishment processing were measured behav-
iourally using the deterministic reversal paradigm employed
previously (Cools et al. 2006a, 2008 #681). Readers are
referred to Cools et al. (2006a) for a more comprehensive
description and a diagram. Briefly, subjects were presented
with two stimuli, one scene and one face, throughout the
experiment. At any given point in time, one stimulus was
associated with reward, whilst the other was associated with
punishment. On each trial, one stimulus was highlighted by
a thick black border, and subjects had to predict (via a
button box) whether the highlighted stimulus would lead to
reward or punishment. Subjects were then shown the actual
outcome. Reward consisted of a green smiley face, a ‘+
$100’ sign and a high-frequency jingle tone. Punishment
consisted of a red sad face, a ‘−$100’ sign and a single low-
frequency tone. Subjects were not given direct performance
feedback and could only determine their accuracy by
remembering their prediction and comparing it to the actual
outcome. The stimulus–outcome contingencies reversed
multiple times and provided attainment of a variable
learning criterion (mean=6.9, SD=1.8, range from 5 to 9
trials).
There were two types of experimental block. In the
reward condition, reversals were signalled by providing
subjects with unexpected reward following a stimulus
previously associated with punishment (i.e., subjects pre-
dicted punishment based upon the previous trials, but the
stimulus was unexpectedly followed by reward), whilst in
the punishment condition, reversals were signalled by
unexpected punishment. The maximum number of reversal
stages per experimental block was 16, although the block
terminated automatically after completion of 120 trials
(6.6 min). Subjects completed two blocks of reward
reversals and two blocks of punishment reversals. Thus
each subject performed 480 trials (four blocks) per
experimental session. The order of conditions was counter-
balanced between subjects.
Performance was assessed by examining proportional
errors on four trial trial-types: expected (non-reversal)
reward, expected punishment, unexpected (reversal) reward
and unexpected punishment trials. Only trials that followed
correct responses were included in the non-reversal trial
analysis. Errors on the trial immediately following the
unexpected feedback were included in the reversal error
analysis. Unexpected reward trials were collapsed across
the two unexpected reward blocks (and vice versa for
punishment), whilst expected reward and punishment trials
were collapsed across all unexpected reward and unexpect-
ed punishment blocks. Reversal and non-reversal trials
were assessed using separate repeated measures ANOVAs.
Error rates were transformed into proportional scores (as
the number of errors varied as a function of performance;
reversal errors were proportional to the number of reversal
trials and non-reversal errors were proportional to the
number of non-reversal trials) and arcsine transformed
(2×arcsine (√x)) as is appropriate when the variance is
proportional to the mean (Howell 2002). Analysis was
performed with these transformed proportional scores.
Results
Biochemical measures
The ratio of TYR/PHE:∑LNAAs was calculated from
measures at baseline and at (approximately) 4.5 h post
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subject factors (drink: BAL vs TYR; time: baseline vs
4.5 h) and one between subject factor (gender) was carried
out. As expected, there was a highly significant drink×time
interaction (F1,24=51.6, p<0.001), with no effects of
gender (drink × time × gender F1,24=0.021, p=0.89).
Breakdown into simple effects showed that there was a
significant effect of time on the depletion day (F1,24=157.3,
p<0.001, which did not interact with gender, F1,24=1.0, p=
0.33) but not on the balanced day (F1,24=2.7, p=0.11; also
no time × gender interaction, F1,24=1.2, p=0.29). More-
over, the ratio at 4.5 h post drink was significantly lower
after the TYR drink compared with the BAL drink (F1,24=
83, p<0.001; no interaction with gender, F1,24=1.0, p=
0.98), whereas there was no difference between the ratios at
baseline on each of the two test days (F1,24=1.2, p=0.29;
no interaction with gender, F1,24=1.0, p=0.84). This is
shown in Tables 2 and 3.
State measures
There was a main effect of time (F2,23=6.5, p=0.006) that
was driven by a shift away from the happy end of the VAS
scale over the course of the day, but there was no effect of
drink (F1,24<0.0001, p=0.99) nor a drink × time interaction
(F2,23=0.46, p=0.6). There was also no drink by gender
interaction (F1,24=0.65, p=0.4) or a drink × time × gender
interaction (F2,23=0.3, p=0.7). Thus, the APTD manipu-
lation had no significant effect upon subjects' moods, and
the behavioural effects cannot be attributed to differential
mood states. This absence of mood effects is consistent
with the effect of tryptophan depletion in healthy individ-
uals (Robinson et al. 2009; Robinson and Sahakian 2009)
and with previous studies of ATPD (Booij et al. 2003; Ruhe
et al. 2007). We aimed to test all female subjects outside of
menses; however, due to time constraints, 5 of the 28
female testing sessions fell either during, or in the week
prior to, menses.
Neuropsychological testing
The results from the experimental paradigm are summar-
ised in Table 4 and Fig. 1.
Comparison between reward- and punishment-based
reversal trials
There was no main effect of either drink (F1,25=1.1, P=
0.31) or valence (F1,25=0.31, P=0.60) on reversal trial
errors. There was, however, a drink × valence × gender
interaction (F1,25=6.5, P=0.02) which was driven by a
valence × gender interaction on the depletion day (F1,26=
4.4, P=0.05) but not on the balanced day (F1,26=1.1, P=
0.31). To break this interaction down further, we next
examined the reward and punishment blocks separately.
Punishment-based reversals
Consistent with the overall model there was a significant
interaction between the effect of APTD on punishment-based
reversaltrialerrorsandgender(drink×gender,F1,25=8.4,P=
0.007). This interaction was driven by a significant improve-
ment after ATPD in punishment reversal trial performance in
female (F1,12=13.3, P=0.003) but not male subjects (F1,13=
2.0, P=0.184). The female-specific effect did not interact
with menses status (drink × menses status, F1,10=0.001, P=
0.97). There was no overall effect of drink (F1,25=0.25, P=
0.62). In sum, APTD improved the ability to reverse
predictions after receiving unexpected punishment in female
but not male subjects (Fig. 1).
Reward-based reversals
There was no effect of APTD on reward-based reversals
(no effect of drink, F1,26=0.87, P=0.36). There was also no
interaction with gender (drink × gender, F1,26=0.58, P=
0.45). APTD therefore had no effect upon the ability to
predict reward.
Non-reversal trials
There was a main effect of valence (F1,25=12.2, P=0.002),
which was driven by increased errors on non-reversal
punishment trials, but no main effect of drink (F1,25=0.45,
P=0.51) or valence × drink interaction (F1,25=0.26, P=
Table 1 Group demographic and trait characteristics: BDI, Beck
Depression Inventory-II; BIS, behavioural inhibition system score;
BAS, behavioural activation system score; IVE, impulsiveness
venturesomeness empathy questionnaire
N Male Female tP
Total 14 14




Age 29 (7.3) 26 (7.0) −0.95 0.35
Weight 79 (12.4) 66 (12.7) −2.4 0.03
BDI 3 (4.4) 3 (3.7) −0.33 0.74
BIS 18 (3.4) 20 (4.0) 1.4 0.17
BAS 37 (6.7) 41 (5.0) 1.7 0.08
IVE-Imp 5 (1.9) 7 (2.6) 1.7 0.10
IVE-Vent 11 (2.7) 10 (3.3) −1.1 0.28
IVE-Emp 11 (2.5) 12 (3.7) 1.8 0.10
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interaction (F1,25=0.62, P=0.44). This increased non-
reversal punishment error rate is consistent with previous
research with the same task (Cools et al. 2008).
Discussion
Consistent with our hypothesis, we demonstrate that DA
depletion improves punishment-based reversal learning,
while leaving reward-based reversal learning unaffected.
However, this effect was gender-specific so that effects
were only observed in female subjects, who are known to
exhibit higher baseline DA levels than do male subjects.
These findings extend a growing body of research
implicating DA in punishment as well as reward processing
(Frank 2005; Seymour et al. 2007; Cohen and Frank 2009;
Cools et al. 2009; Robinson et al. 2010). More specifically,
prior work has shown that increases in DA impair
punishment-based reversal in patients with Parkinson's
disease and healthy volunteers with low DA synthesis
capacity (Cools et al. 2006a, 2009). Thus, low levels of DA
seem beneficial for learning from punishment. This concurs
with recent theoretical modelling in which increases in DA
impair punishment-based learning by blocking the effects
of punishment-associated DA dips on cortico-striatal action
suppression (Frank 2005; Frank et al. 2007a). The present
data reveal the opposite side of the same coin, i.e., that
decreases in DA can improve punishment-based learning
(here, we do not distinguish between receipt of punishment
and reward omission). Recent fMRI work with this task
adopted in this study suggests that such a shift in responses
may occur either via modulation of a valence non-specific
Pavlovian signal within the anterior ventral striatum or a
reward-specific instrumental-like signal within the posterior
dorsal striatum (Robinson et al. 2010).
It is worth noting that, following the unexpected
outcome, the same stimulus was always highlighted in this
Table 3 Biochemical measures. ATPD causes a significant decrease in the tyrosine/phenylalanine to large neutral amino acids ratio (TYR +
PHE:∑LNAAs) in both males and females (standard error of the mean, SEM)
Absolute values (nmol/ml)
T1 T2
Try Phe Try Phe
BAL
Male 48.63 (7.43) 69.38 (6.02) 68.66 (10.00) 179.38 (26.91)
Female 42.47 (4.92) 78.42 (5.29) 58.16 (4.24) 178.34 (16.52)
ATPD
Male 47.39 (5.03) 81.57 (5.92) 25.63 (1.89) 39.41 (4.56)
Female 48.16 (4.31) 86.29 (6.51) 30.50 (3.36) 40.15 (3.66)
T1 baseline measurement taken following fasting and prior to drink administration. T2 4.5 h following drink administration, directly prior to
neuropsychological testing began. BAL amino acid balanced drink (placebo condition). ATPD drink lacking in tyrosine or phenylalanine to
produce the acute tyrosine/phenylalanine depletion low DA synthesis condition
Table 2 Biochemical measures. ATPD causes a significant decrease in the tyrosine/phenylalanine to large neutral amino acids ratio (TYR +
PHE:∑LNAAs) in both males and females (standard error of the mean, SEM)
Ratios T1 T2
Tyr + Phe: ∑LNAAS Tyr: ∑LNAAS Phe: ∑LNAAS Tyr + Phe: ∑LNAAS Tyr: ∑LNAAS Phe: ∑LNAAS
BAL
Male 0.30 (0.04) 0.13 (0.02) 0.17 (0.02) 0.29 (0.04) 0.08 (0.01) 0.21 (0.04)
Female 0.36 (0.03) 0.13 (0.02) 0.23 (0.02) 0.29 (0.03) 0.07 (0.01) 0.22 (0.02)
ATPD
Male 0.34 (0.03) 0.12 (0.01) 0.21 (0.02) 0.07 (0.01) 0.03 (0.00) 0.04 (0.00)
Female 0.39 (0.04) 0.14 (0.02) 0.25 (0.03) 0.07 (0.01) 0.03 (0.00) 0.04 (0.00)
T1 baseline measurement taken following fasting and prior to drink administration. T2 4.5 h following drink administration, directly prior to
neuropsychological testing began. BAL amino acid balanced drink (placebo condition). ATPD drink lacking in tyrosine or phenylalanine to
produce the acute tyrosine/phenylalanine depletion low DA synthesis condition
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primarily the breaking of a prepotent stimulus–reward link, as
well as the formation of a new stimulus–punishment link.
Conversely, reward-based reversal required primarily the
breaking of a prepotent stimulus–punishment link and the
formation of a new stimulus-reward link. We hypothesise that
the effect of ATPD on punishment-based reversal likely
reflected the breaking of the old prepotent stimulus–reward
link rather than the formation of a new stimulus–punishment
link, based on two observations. First, we observed no effect
of ATPD on the punishment non-reversal trials (although we
cannot be sure that the non-reversal trials were sufficiently
sensitive to detect punishment-related learning, given that the
task contingencies were deterministic and learning likely
occurredonanapproximatelysingletrialbasis).Second,there
is precedence for the importance of dopamine in the breaking
of prepotent stimulus–reward links. Specifically, injection of
D-amphetamine in the NAc of rats potentiates behavioural
control by stimuli formerly associated with reward (i.e.,
conditioned reinforcement) in a DA-dependent way
(Robbins et al. 1989). The observation that this D-amphet-
amine induced potentiation of control by previously
rewarded stimuli was abolished by lesions of the ventral
striatum (the nucleus accumbens) (Parkinson et al. 2002)
strengthens the hypothesis that the striatum might play a role
in the effects shown here. Evidence for this hypothesis
comes from a series of recent studies (Cools et al. 2007;
Dodds et al. 2008; Clatworthy et al. 2009) showing that
effects of DA-enhancing drugs (LDOPA in PD and
methylphenidate in healthy volunteers) are accompanied by
modulations of BOLD signals in the ventral striatum during
punishment-based reversal learning. Furthermore, Goto and
Grace (2005) have revealed that increases in tonic DA
release in the ventral striatum and administration of a DA
(D2) receptor agonist in the ventral striatum disrupted PFC-
evoked responses in the ventral striatum and impaired
behavioural reversal learning in rats. Thus, the DA-
enhancing drugs in these studies may have induced aberrant
potentiation of control by previously rewarded stimuli and
disrupted input to the striatum, signalling the need for a
switch. By analogy, DA depletion in the present study may
have attenuated potentiation of control by previously
rewarded stimuli and may have enhanced input to the
striatum, signalling the need for a switch.
The present findings suggest, however, that this effect
may depend on gender. This is consistent with the
previously observed gender disparity in DA synthesis
capacity. Female subjects have been shown to have
increased DA synthesis relative to males (Laakso et al.
2002), and punishment processing is shown to be impaired
in individuals with high baseline DA synthesis (Cools et al.
2009). As such, the improvement in punishment processing
Fig. 1 Dissociable effects on valence specific reversal learning in
males and females. In females, tyrosine depletion significantly
improved punishment-based reversal (a) relative to the non-depleted
day. There was no similar effect on reward-based reversal (b)o ri n
males (see also Table 4). Values represent the mean; error bars
represent standard error of the mean
BAL ATPD
PUN REW PUN REW
A) Reversal trials
Male 8.302 (2.84) 10.985 (2.54) 12.115 (3.23) 8.122 (2.68)
Female 9.465 (2.94) 6.953 (2.64) 5.676 (3.35) 7.333 (2.78)
B) Non-reversal trials
Male 4.73 (0.98) 5.65 (0.96) 3.85 (0.98) 4.90 (0.85)
Female 4.05 (1.02) 3.32 (0.99) 5.45 (1.01) 3.05 (0.88)
Table 4 Neuropsychological
measures. Percentage error rates
(standard error of the mean,
SEM) on punishment (PUN)
and reward (REW) A) reversal
trials and B) non-reversal trials
in the placebo (BAL) and acute
tyrosine/phenylalanine depletion
(ATPD) conditions. N.B. there
was no effect of gender in the
non-reversal trials; data stratified
for illustration purposes only
192 Psychopharmacology (2010) 211:187–195following DA reduction in females may be driven by a
greater ATPD-induced deviation from this putatively higher
baseline DA synthesis rate in females relative to males
(although future work in which we directly measure DA
synthesis [rather than levels of amino acid precursors]
across genders under both conditions is necessary to test
this hypothesis more thoroughly).
Intriguingly, the effect that we see here is distinct from
the effects of reducing serotonin on the same task. Acute
tryptophan depletion (ATD), which is similar in principle to
ATPD, reduces the serotonin precursor tryptophan and has
been used to reduce serotonin in subjects completing this
task. ATD influenced performance on non-reversal punish-
ment trials, rather than on punishment reversal trials seen in
these findings (Cools et al. 2008) (although, note that we do
replicate the increased unexpected (non-reversal) punish-
ment errors). It also should be noted, however, that
although gender effects were not seen in the prior ATD
study, the sample size in that study was not large enough to
enable such analysis. Other studies within our lab have in
fact shown gender-specific effects of ATD on cognitive
processing (Robinson et al. 2009; Robinson and Sahakian
2009), but additional research with the present task would
be required to determine the effects of gender on serotonin
manipulation of this task.
The gender biases in the response to neurotransmitter
precursor depletion are particularly interesting in the light of
the gender biases in the susceptibility to affective disorders.
Females are, for instance, much more likely to become
depressed than males (Nolen-Hoeksema et al. 1999) but tend
to experience a more benign form of PD with a later onset
than males (Haaxma et al. 2007). The gender-specific effects
of depletion may be driven by, for example, differential
baseline levels of neurotransmitters, differential rates of
precursor absorption or differential rates neurotransmitter
production, and this, may in turn, influence susceptibility to
affective disorders. Indeed, susceptibility to affective biases
following precursor depletion may provide a means of
predicting susceptibility to affective disorders, although
future work is clearly necessary to clarify this.
It should be noted that the affective bias that we see here
was found in the absence of any effects on mood. This is
consistent with a number of prior ATPD (and ATD) studies
in healthy individuals (Booij et al. 2003), and it is now
thought that the link between monoamines and mood state
is indirect (Ruhe et al. 2007). As such, the affective biases
seen here may represent alterations in ‘emotional’ process-
ing (the short-term affective response to distinct stimuli)
rather than alterations in ‘mood’ states (long-term changes
in affective state with diverse, unclear causes; Robinson
and Sahakian 2009). It should also be noted that whilst the
BAL drink did not cause depletion, it is still a somewhat
artificial situation compared with normal food consump-
tion. As such, caution should be exercised when comparing
the BAL condition to “healthy” performance. As a further
caveat, it should be noted that we did not have the facility
for more comprehensive screening methods that are
sometimes used (e.g., a urine drug screen). However, we
would point out that the mean BDI score (3; Table 1) puts
the sample firmly within the lowest category (cut off 13) of
depressive symptoms (“minimal depression”). Crucially,
this was also equivalent across males and females (as,
indeed were all the trait measures taken). Indeed, given that
over 50% of the sample had an education level higher than
BA, there is a possibility that this is a hyper performing
sample. Again, care should be exercised when extrapolating
these findings to the population as a whole.
One advantage of the ATPD method is that it should
promote a global reduction in DA rather than focusing upon
a specific subtype (i.e., D1 or D2), but it is, nevertheless, an
imperfect technique. Previous research has shown effects to
be modest on some aspects of cognition (Booij et al. 2003;
Roiser et al. 2005) and, given that noradrenaline (NA) is
synthesised from DA, it may also influence NA levels.
However, as highlighted by Roiser et al. (2005), a number
of lines of evidence suggest that this is not the case. Firstly,
ATPD attenuates D-amphetamine-induced DA efflux
(Leyton et al. 2003; McTavish et al. 1999a; McTavish et
al. 1999b) but has no effect upon NA response to
amphetamine or idazoxan; secondly, ATPD also only
influences the DA-mediated subjective effects of D-amphet-
amine (e.g., the ‘buzz’) and not influence the NA-
associated effects (e.g., hunger) (McTavish et al. 1999c;
although see Leyton et al. 2005, 2007); and thirdly, ATPD
has no effect on melatonin levels (which are controlled by
NA) but does influence prolactin levels (which are
controlled by DA) (Sheehan et al. 1996; Harmer et al.
2001). It should be noted as a limitation that the
venipuncture method of blood sample collection used in
this study causes short-term stress (influencing prolactin
levels) and is therefore unreliable as means of assessing
prolactin levels. Future research should use cannulation to
adequately assay prolactin.
In sum, this study strengthens previous observations that
DA plays an important role in punishment processing but
suggests that it may be dependent upon gender. It is
conceivable that this disproportionate sensitivity to DA
depletion of females is due to increased levels of baseline
DA in females relative to males, although further work is
necessary to clarify this. However, these findings further
cement the role of DA in punishment processing and
underline the importance of gender in the neuropharmacol-
ogy of cognitive processing. Such gender differences may
shed light on the gender biases in susceptibility to and
severity of psychiatric diseases like Parkinson's disease or
depression.
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